In this study, we used the CD133 antigen as a cancer stem-cell marker in order to identify, within stabilized osteosarcoma cell lines, cells exhibiting different properties in terms of proliferation rate, clonogenic efficiency, sphere-cluster formation and dye exclusion. The gene discussed is PROM1; the disease is cancer.